CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans
Starting July 1, Caremark will prioritize Wegovy on its formulary, making the weekly injection more accessible to its members.
Related Articles
Youth-Onset Type 2 Diabetes: What We’ve Learned From Key Youth-Onset Type 2 Diabetes Studies, What We Still Don’t Know, and Why It Is Important
In this review, we describe the epidemiology, pathophysiology, pediatric-specific treatment response data, morbidity, and mortality of youth-onset type 2 d
Anthropic’s Claude can now generate invoices on PayPal and analyze sales on Square
Anthropic announced a set of integrations on Thursday that allow its Claude AI service to take actions on a user’s behalf.
Republicans weigh cuts to Medicaid that could dramatically affect millions
President Donald Trump’s fellow Republicans in the U.S. Congress are weighing steep cuts to the Medicaid health program as part of a wide-ranging budget package…
Disproportionate increase in BMI of ≥60 kg/m2 in the USA
The obesity epidemic has reached alarming levels, with most attention focusing on obesity in general (BMI >30 kg/m2) and class 3 obesity (BMI ≥40 kg/m2).1–3…
Trump blames Biden ‘overhang’ after GDP shrinks in first quarter, says growth will ‘take a while’
President Donald Trump blamed his predecessor and defended his sweeping tariffs after new data showed the U.S. economy contracting last quarter.
Why our waistlines expand in middle age: Stem cells
It’s no secret that our waistlines often expand in middle-age, but the problem isn’t strictly cosmetic. Belly fat accelerates aging and slows down metabolism, increasing…
High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial
OBJECTIVE. Studies have demonstrated dose-dependent efficacy of glucagon-like peptide 1 receptor agonists for glycemic control and body weight. The aim of
One-Year Outcomes of SADI-S in Chinese Patients with Type 2 Diabetes and BMI < 35 kg/m2: A Single-Center Retrospective Study
Obesity Surgery – There is limited evidence on the efficacy and safety of single anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) in treating type 2…
Human adaptation response to obesity
International Journal of Obesity – Human adaptation response to obesity
The robot in the room: It’s time for an honest conversation about value
Somedays it feels like we are living in a postscientific world, where no one is asking the important but perhaps inconvenient questions—and then a paper…